Status:
COMPLETED
Soft Tissue Management in Peri-Implant Regions
Lead Sponsor:
Ömer Alperen Kırmızıgül
Collaborating Sponsors:
Inonu University
Conditions:
Peri-implant Mucosa Thickness
Peri-implant Mucosa Width
Eligibility:
All Genders
18-60 years
Phase:
NA
Brief Summary
Background:This study aimed to compare the effect of ribose cross-linked thick collagen membrane (RCCM) with that of subepithelial connective tissue graft (CTG) in sites with soft tissue deficiency in...
Eligibility Criteria
Inclusion
- Systemically healthy
- The edentulous space for which implant treatment is planned to be single tooth size and molar tooth site
- Those with soft tissue deficiency in the horizontal aspect in the site where implant treatment is planned
- Age between 18-60 years
- Does not have a condition that may cause a bleeding disorder
- No nausea-vomiting reflex
- Patients with good oral hygiene
Exclusion
- Patients with systemic disorders (diabetes, hypertension, radiotherapy/ chemotherapy, etc.)
- Patients who have insufficient horizontal alveolar bone in the site where implant treatment is planned and who may lead to bone dehiscence after implant placement
- Patients with collagen allergy
- Those taking any medication that may affect wound healing
- Those with bleeding disorders
- Smokers who smoke more than 10 cigarettes a day
- Poor oral hygiene
- Those with vomiting-nausea reflex
- Allergic to anti-inflammatory drugs
- Patients with pregnancy/breastfeeding status.
Key Trial Info
Start Date :
December 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 30 2024
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT06880185
Start Date
December 1 2023
End Date
December 30 2024
Last Update
December 9 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Inonu Unıversity Faculty of Dentistry
Malatya, Turkey (Türkiye)